The pharmaceutical industry stands on the brink of a technological revolution with the recent release of the Good Automated Manufacturing Practice (GAMP) Artificial Intelligence Guide by the International Society for Pharmaceutical Engineering (ISPE). As pharmaceutical companies increasingly turn
The cell and gene therapy (CGT) market is undergoing rapid expansion as it transforms healthcare with innovative treatments for previously incurable diseases. This exhilarating growth is projected to reach $28 billion by the year 2030, marking a significant milestone. Experts attribute this
At the crossroads of artificial intelligence and biology lies a transformative opportunity poised to redefine the boundaries of medical science. The GREmLN initiative, spearheaded by the Chan Zuckerberg Initiative in collaboration with New York Biohub, aims to bridge these two disciplines in a
In a decisive leap toward revolutionizing gene therapy, ProBio has unveiled its cutting-edge facility in Hopewell, New Jersey. This facility is poised to become a key player in the production of high-quality plasmid, lentiviral, and adeno-associated viral vectors tailored for genomic medicine. With
The biomanufacturing industry is witnessing a significant shift as innovative microcarrier technologies emerge, promising to alter the conventional methods of cell-based production. At the forefront of this transformation is the collaboration between Smart MCs and the University of New South Wales
Drawing from years of experience in biopharmaceutical research and innovation, Ivan Kairatov is known for his insightful contributions to healthcare advancements. With the recent recognition of Tagomics Ltd. through a substantial grant from Innovate UK for colorectal cancer research, Ivan is poised
